Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18656 | 541 | 26.1 | 37% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
141 | 3 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS | 64640 |
373 | 2 | MYCOBACTERIUM TUBERCULOSIS//TUBERCULOSIS//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES | 17241 |
18656 | 1 | CLOFAZIMINE//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES//B669 | 541 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CLOFAZIMINE | authKW | 457588 | 6% | 27% | 30 |
2 | INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES | journal | 309455 | 14% | 7% | 76 |
3 | B669 | authKW | 282207 | 1% | 100% | 5 |
4 | CAS 2030 63 9 | authKW | 225765 | 1% | 100% | 4 |
5 | RIMINOPHENAZINES | authKW | 225765 | 1% | 100% | 4 |
6 | ANTILEPROTICS | authKW | 169324 | 1% | 100% | 3 |
7 | INTRABACTERIAL NA K RATIO | authKW | 169324 | 1% | 100% | 3 |
8 | ANTILEPROSY DRUGS | authKW | 126991 | 1% | 75% | 3 |
9 | AURAMINE O RHODAMINE B | authKW | 112883 | 0% | 100% | 2 |
10 | 2 METHOXYPYRIDYLAMINO SUBSTITUTED RIMINOPHENAZINES | authKW | 56441 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Tropical Medicine | 13262 | 23% | 0% | 127 |
2 | Microbiology | 2647 | 30% | 0% | 161 |
3 | Infectious Diseases | 1080 | 14% | 0% | 75 |
4 | Dermatology | 638 | 9% | 0% | 47 |
5 | Pharmacology & Pharmacy | 518 | 20% | 0% | 108 |
6 | Pathology | 405 | 8% | 0% | 45 |
7 | Chemistry, Medicinal | 205 | 6% | 0% | 35 |
8 | Immunology | 153 | 10% | 0% | 53 |
9 | Oncology | 27 | 6% | 0% | 32 |
10 | Parasitiology | 26 | 2% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADV STUDY CRYSTALOG BIOPHYS | 56441 | 0% | 100% | 1 |
2 | BEIJING CITY ACT SUBST DISCOVERY DRUG A | 56441 | 0% | 100% | 1 |
3 | DHHS HRSA HSB HANSENS DIS PROGRAMS | 56441 | 0% | 100% | 1 |
4 | EXCELLENCE BIOMED MRC NHLS WITS MOL MYCOB | 56441 | 0% | 100% | 1 |
5 | IMMUNOLUNIT INFLAMMAT IMMUNMRC | 56441 | 0% | 100% | 1 |
6 | KOGA HOSP | 56441 | 0% | 100% | 1 |
7 | MED LEPROSY | 56441 | 0% | 100% | 1 |
8 | MOL CARDIOL DRUG DISCOVERY | 56441 | 0% | 100% | 1 |
9 | MRCUNIT INFLAMMAT IMMUNITY | 56441 | 0% | 100% | 1 |
10 | PATHOLMRCUNIT INFLAMMAT IMMUN | 56441 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES | 309455 | 14% | 7% | 76 |
2 | LEPROSY REVIEW | 55397 | 7% | 3% | 37 |
3 | ANNALES DE MICROBIOLOGIE | 11440 | 2% | 2% | 9 |
4 | JOURNAL OF GENERAL MICROBIOLOGY | 5654 | 4% | 0% | 23 |
5 | MICROBIOS | 5213 | 2% | 1% | 12 |
6 | PROGRESS IN MEDICINAL CHEMISTRY | 3134 | 0% | 6% | 1 |
7 | CHEMOTHERAPY | 2211 | 2% | 0% | 10 |
8 | ANNALES DE L INSTITUT PASTEUR-MICROBIOLOGIE | 1855 | 1% | 1% | 3 |
9 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1268 | 2% | 0% | 10 |
10 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1231 | 4% | 0% | 23 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLOFAZIMINE | 457588 | 6% | 27% | 30 | Search CLOFAZIMINE | Search CLOFAZIMINE |
2 | B669 | 282207 | 1% | 100% | 5 | Search B669 | Search B669 |
3 | CAS 2030 63 9 | 225765 | 1% | 100% | 4 | Search CAS+2030+63+9 | Search CAS+2030+63+9 |
4 | RIMINOPHENAZINES | 225765 | 1% | 100% | 4 | Search RIMINOPHENAZINES | Search RIMINOPHENAZINES |
5 | ANTILEPROTICS | 169324 | 1% | 100% | 3 | Search ANTILEPROTICS | Search ANTILEPROTICS |
6 | INTRABACTERIAL NA K RATIO | 169324 | 1% | 100% | 3 | Search INTRABACTERIAL+NA+K+RATIO | Search INTRABACTERIAL+NA+K+RATIO |
7 | ANTILEPROSY DRUGS | 126991 | 1% | 75% | 3 | Search ANTILEPROSY+DRUGS | Search ANTILEPROSY+DRUGS |
8 | AURAMINE O RHODAMINE B | 112883 | 0% | 100% | 2 | Search AURAMINE+O+RHODAMINE+B | Search AURAMINE+O+RHODAMINE+B |
9 | 2 METHOXYPYRIDYLAMINO SUBSTITUTED RIMINOPHENAZINES | 56441 | 0% | 100% | 1 | Search 2+METHOXYPYRIDYLAMINO+SUBSTITUTED+RIMINOPHENAZINES | Search 2+METHOXYPYRIDYLAMINO+SUBSTITUTED+RIMINOPHENAZINES |
10 | 25 KDA MYCOBACTERIAL FRACTION | 56441 | 0% | 100% | 1 | Search 25+KDA+MYCOBACTERIAL+FRACTION | Search 25+KDA+MYCOBACTERIAL+FRACTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OCONNOR, R , OSULLIVAN, JF , OKENNEDY, R , (1995) THE PHARMACOLOGY, METABOLISM, AND CHEMISTRY OF CLOFAZIMINE.DRUG METABOLISM REVIEWS. VOL. 27. ISSUE 4. P. 591-614 | 38 | 61% | 27 |
2 | HARSHAN, KV , MITTAL, A , PRASAD, HK , MISRA, RS , CHOPRA, NK , NATH, I , (1990) UPTAKE OF PURINE AND PYRIMIDINE NUCLEOSIDES BY MACROPHAGE-RESIDENT MYCOBACTERIUM-LEPRAE - H-3 ADENOSINE AS AN INDICATOR OF VIABILITY AND ANTIMICROBIAL ACTIVITY.INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES. VOL. 58. ISSUE 3. P. 526-533 | 22 | 96% | 4 |
3 | CHOLO, MC , STEEL, HC , FOURIE, PB , GERMISHUIZEN, WA , ANDERSON, R , (2012) CLOFAZIMINE: CURRENT STATUS AND FUTURE PROSPECTS.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 67. ISSUE 2. P. 290-298 | 23 | 34% | 64 |
4 | WHEELER, PR , (1990) RECENT RESEARCH INTO THE PHYSIOLOGY OF MYCOBACTERIUM-LEPRAE.ADVANCES IN MICROBIAL PHYSIOLOGY. VOL. 31. ISSUE . P. 71-124 | 54 | 36% | 7 |
5 | WIESE, M , LINDNER, B , SEYDEL, U , (1994) DEVELOPMENT OF AN IN-VITRO DRUG SCREENING SYSTEM FOR MYCOBACTERIUM-LEPRAE BASED ON THE DETERMINATION OF THE INTRABACTERIAL SODIUM TO POTASSIUM RATIO OF INDIVIDUAL BACTERIAL ORGANISMS.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 4. ISSUE 4. P. 271-279 | 18 | 90% | 0 |
6 | LAHIRI, R , RANDHAWA, B , KRAHENBUHL, J , (2005) APPLICATION OF A VIABILITY-STAINING METHOD FOR MYCOBACTERIUM LEPRAE DERIVED FROM THE ATHYMIC (NU/NU) MOUSE FOOT PAD.JOURNAL OF MEDICAL MICROBIOLOGY. VOL. 54. ISSUE 3. P. 235-242 | 17 | 61% | 36 |
7 | TONELLI, M , NOVELLI, F , TASSO, B , SPARATORE, A , BOIDO, V , SPARATORE, F , CANNAS, S , MOLICOTTI, P , ZANETTI, S , PARAPINI, S , ET AL (2014) ANTITUBERCULAR ACTIVITY OF QUINOLIZIDINYL/PYRROLIZIDINYLALKYLIMINOPHENAZINES.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 22. ISSUE 24. P. 6837 -6845 | 15 | 52% | 0 |
8 | ZHANG, DF , LIU, Y , ZHANG, CL , ZHANG, H , WANG, B , XU, J , FU, L , YIN, DL , COOPER, CB , MA, ZK , ET AL (2014) SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL 2-METHOXYPYRIDYLAMINO-SUBSTITUTED RIMINOPHENAZINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS.MOLECULES. VOL. 19. ISSUE 4. P. 4380-4394 | 8 | 89% | 5 |
9 | VAN RENSBURG, CEJ , JOONE, GK , O'SULLIVAN, JF , (2000) TETRAMETHYLPIPERIDINE-SUBSTITUTION INCREASES THE ANTITUMOR ACTIVITY OF THE RIMINOPHENAZINES FOR AN ACQUIRED MULTIDRUG-RESISTANT CELL LINE.ANTI-CANCER DRUG DESIGN. VOL. 15. ISSUE 4. P. 303 -306 | 13 | 81% | 8 |
10 | BANNIGAN, P , ZEGLINSKI, J , LUSI, M , O'BRIEN, J , HUDSON, SP , (2016) INVESTIGATION INTO THE SOLID AND SOLUTION PROPERTIES OF KNOWN AND NOVEL POLYMORPHS OF THE ANTIMICROBIAL MOLECULE CLOFAZIMINE.CRYSTAL GROWTH & DESIGN. VOL. 16. ISSUE 12. P. 7240 -7250 | 15 | 44% | 0 |
Classes with closest relation at Level 1 |